LTS is a leader in the transdermal area with a successful and proven track record. Throughout the last 30 years, LTS has developed more than 20 products which have been successfully commercialized by our pharmaceutical partners.
As a manufacturing and development company of drug delivery systems, LTS is not involved in marketing and distribution of pharmaceutical products.
LTS is open and free to cooperate with its partners based on their requirements. Typical ways of cooperation are:
• Development of transdermal systems or flat film-forming dosage forms for oral application in joint cooperation with pharmaceutical partners. As a result of this cooperation the distribution and marketing rights belong exclusively to the pharmaceutical company, and LTS retains the manufacturing rights.
• Own-funded developments are licensed to other companies retaining the rights of manufacturing.
• Toll manufacturing of patches and oral film forms developed by third parties.
As full service company LTS has the capabilities and facilities to do all facets of product development from feasibility of final production;
LTS is worldwide the only manufacturer of transdermal systems and oral film forms who has FDA-approved production plants with identical equipment on two continents to serve customers. Its state of the art facilities are in GMP compliance and actively producing FDA approved products. The production sites have a capacity of several billion systems per year. Experience from having delivered large commercial quality of patches and oral film forms in the last 30 years makes LTS unique in this field.
LTS has patented various transdermal patch technologies including drug in adhesive matrix systems, multilayered matrix systems as well as different types of reservoir systems (liquid and semi solid reservoir). LTS has prior experience and in-house technical knowledge which allow the utilization of drug incorporation to all types of adhesives including: silicones, PIB's and acrylics.
Moreover, LTS has developed patented technologies for flat film-forming dosage forms for oral drug delivery ranging from flash-release wafer systems to mucoadhesive buccal patch systems.
In addition, LTS offers service for clinical evaluation through a wholly owned CRO, located in Germany.
Head of Business Development
Dr Stefan Arnold
Head of Business Development Asia
Clients in focus...